The global cell and tissue culture supplies market was at a market value of $21.19B in 2021 and is expected to generate a revenue of $45B by 2028 while growing at a CAGR of 11.2% during the forecast period.
The global cell and tissue culture supplies market was at a market value of $21.19B in 2021 and is expected to generate a revenue of over $45B by 2028 while growing at a CAGR of 11.2% during the forecast period. The report analyzes the cell and tissue culture supplies market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the cell and tissue culture supplies market.
Cell and tissue culture is the building block of biotechnology and refers to the process of keeping the cells or tissues outside their source in an artificial environment, alive, and healthy. The main goal of cell culture systems is to keep the cells that were earlier in the 3-D environment in tissues, cultured and necessary examinations are conducted by keeping them in the right circumstances and under in vitro conditions. Cell and tissue culture supplies are extremely important in the process of analyzing cells or tissues because they assist in maintaining the authenticity of the culture being processed, restrict the contamination of cells or tissues, and provide an optimum environment for them to grow as they would if they were in their natural source.
The global cell and tissue culture supplies market is driven by the necessity to gain as much knowledge as possible on cells or tissues which are the most critical component of any living organism and form the basis of its existence. As the biopharmaceutical market grows, the demand for supplies to cultivate cells & tissues is expected to grow along with it given the immense help these supplies provide in storing such culture.
The global market was impacted positively by the onset of Covid-19. Since Covid-19 was a new virus with the pharmaceutical or healthcare agencies having no prior knowledge of the virus, it was heavily researched on when it started spreading globally. Since the virus has shown multiple mutations and is likely to stay for a longer time than earlier anticipated, it is still being researched along with ongoing treatments for the patients which are anticipated to aid the global market growth in the coming years as well.
Extensive R&D in pharmaceutical and biotechnology sectors to propel market growth
Covid-19 caught many nations off-guard. It acted as a wake-up call for many governments to start preparing for such fatal biological viruses that leave a long-lasting impact not just on the general population but on the overall economy of the nation. Research and development activities have always been at the core of the global healthcare infrastructure but it grew even more post-2020 forcing government agencies, private companies, and global healthcare agencies to encourage as much research on the understanding of the interconnection and the effect organisms have on one another when they come together. This is possible only through developing cell and tissue cultures outside their natural source and studying them under different conditions while keeping them in man-made medical environments. This is expected to aid the growth of the global cell and tissue culture supplies market in the coming years.
The rise in the number of medical cases, chronic diseases, and rising pressure on medical experts to come up with solutions for diseases that have long prevailed without any medical solution like AIDS, cancer, and diabetes is projected to propel the need for cell and tissue culture supplies in the coming years.
High cost and ethical concerns related to cell and tissue culture may restrain the market growth
Setting up facilities that can cultivate cells or tissues is an expensive affair. Some of the equipment required for the process have extremely high cost and pose affordability issues for many underdeveloped or developing nations. Even if these nations can set up some cell and tissue culture facilities, the number is quite low and they require heavy funding to open up more research facilities which are projected to restrict the global cell and tissue culture supplies market growth.
Given the critical & highly confidential data that is generated when cells or tissues are studied and the implications this data may have globally, there is a growing concern about unethical ways of cultivating cells and tissues without following standard protocol and under wrong conditions thus restraining the global market expansion.
Emergence of new and unique viruses in remote areas along with rising demand for 3D cell culture to provide lucrative growth opportunities
Not just Covid-19, but there has been a significant rise in the number of previously undetected viruses that affect not just humans but animals too. This has aided the growth in the actions toward learning about cells and tissues to become better prepared for the future which is expected to aid the growth in the global market.
The rising interest of many key players in biotechnology along with government initiatives to encourage private investments in the healthcare field assisted by rising demand for 3D cell culture may provide for growth opportunities during the forecast period.
Stringent certification and licensing government rules to pose challenges in the market
Given the sensitivity of cell and tissue cultures, government and international healthcare agencies have laid down strict protocols or rules for generating licenses and registering cell and tissue cultivating facilities. Even the facilities already established have to undergo inspection at regular intervals and the license can be revoked in case of any malpractice or falling short of following the set protocols. This is projected to create challenging situations for global market growth as many investors may find these rules too tedious to follow.
The global cell and tissue culture supplies market is segmented by instruments, type, consumables, and region.
Based on instruments, the global market is segmented into biosafety cabinets, cryostorage equipment, incubators, and pipetting instruments where cryostorage equipment and incubators may lead the segment.
Based on type, the global market segments are Petri dishes, roller bottle culture apparatus, culture systems & bioreactors, culture cylinders, spreaders, syringe fillers, serological pipettes, scrapers & lifters, and tissue grinders.
By consumables, the global market is segmented as sera, contamination detection kits, reagents, media, and cryoprotective agents. The consumables segment is anticipated to dominate all the other segments because of the higher demand for consumables in the market since the frequent purchase of these products has been observed since 2020 and higher funding for research on cells.
Report Scope:
North America followed by Asia-Pacific to dominate the global market
North America dominated the global market in the previous years and is expected to follow the same trend in the coming years owing to the existence of large-scale cell and tissue culture supplies manufacturers along with the ready availability of monetary support from the government. The rising need for more exhaustive studies on cells and tissues may propel regional growth.
Asia-Pacific may register the highest CAGR during the forecast period because of regions like India and China because of the rising interest of key players to set up manufacturing units in these economies owing to the presence of skilled labor at a relatively affordable price. China is investing heavily in the R&D activities conducted in the region and the number of clinical trials has increased significantly.
In Europe, Germany is being considered a hotspot for the cell and tissue culture supplies market because of the rising number of cancer patients in the country thus pushing the need for research on the diseases.
Some of the players in the global cell and tissue culture supplies market are Danaher Corporation, Merck KGaA, Fisher Scientific Inc., Sartorius AG, Dickinson and Company, Lonza Group, and Eppendorf AG.
By Instruments:
By Type:
By Consumables:
By Region
FrequentlyAsked Questions
Extensive R&D in pharmaceutical and biotechnology sectors along a rise in the number of medical cases, chronic diseases, and rising pressure on medical experts to come up with solutions for diseases that have long prevailed without any medical solution like AIDS, cancer, diabetes is projected to propel the need for cell and tissue culture supplies in the coming years.
As per Zion Market Research, the global cell and tissue culture supplies market was at a market value of $21.19B in 2021 and is expected to generate a revenue of $45B by 2028 while growing at a CAGR of 11.2% during the forecast period.
North America dominated the global market in the previous years and is expected to follow the same trend in the coming years owing to the existence of large-scale cell and tissue culture supplies manufacturers along with the ready availability of monetary support from the government. The rising need for more exhaustive studies on cells and tissues may propel regional growth.
Some of the players in the global cell and tissue culture supplies market are Danaher Corporation, Merck KGaA, Fisher Scientific Inc., Sartorius AG, Dickinson and Company, Lonza Group, and Eppendorf AG
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed